The results showing that C/EBPβ levels modified the invasive capacity of NMuMG cells towards TGF-β1 in vitro prompted us to study whether loss of C/EBPβ would affect the metastatic capacity of mammary tumor cells, in vivo. The gene discussed is CEBPB; the disease is breast cancer.